Fortune reported that Myriant has withdrawn its planned $125 million IPO. The publication said that no reasons were given. Based in Quincy, Mass., Myriant is a biochemical company. Its backers include Plainfield Asset Management and PTT Chemical International.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.